SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-12-14 22:07
Tx date 2020-11-30
$PAS
Pascal Biosciences Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$62,170
+310,850 vol
$0.20 each
980,849
Filed 2020-03-06 10:20
Tx date 2020-03-05
$SOC
Sonora Gold & Silver Corp.
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
Options
50 - Grant of options

+600,000 vol
600,000
Filed 2020-03-06 10:19
Tx date 2016-04-28
$SOC
Sonora Gold & Silver Corp.
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-07
Tx date 2018-08-03
$PAS
Pascal Biosciences Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
572,500
Filed 2016-05-03
Tx date 2016-04-28
$SOC
Sonora Gold & Silver Corp.
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
7,964,109
Filed 2016-05-03
Tx date 2016-04-28
$SOC
Sonora Gold & Silver Corp.
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-22
Tx date 2016-04-22
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+23,333 vol
669,999
Filed 2016-04-05
Tx date 2016-04-01
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+22,500 vol
422,500
Filed 2016-03-04
Tx date 2016-03-01
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market

+36,000 vol
110,000
Filed 2016-02-16
Tx date 2016-02-12
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market

+4,000 vol
74,000
Filed 2016-02-05
Tx date 2016-02-02
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market

+10,000 vol
70,000
Filed 2016-02-01
Tx date 2016-01-27
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+5,000 vol
646,666
Filed 2016-01-26
Tx date 2016-01-22
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market

+10,000 vol
60,000
Filed 2015-11-30
Tx date 2015-11-19
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market

+50,000 vol
50,000
Filed 2015-11-30
Tx date 2015-06-30
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-10-05
Tx date 2015-10-02
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+50,000 vol
641,666
Filed 2015-08-11
Tx date 2015-08-04
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$124,000
+400,000 vol
$0.31 each
400,000
Filed 2015-07-10
Tx date 2015-06-30
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-10
Tx date 2015-06-30
$IMU
bioMmune Technologies Inc.
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
591,666